Cencora NYSE Composite Reset Sparks Valuation Debate
Cencora earnings highlight specialty pharma strength, acquisition gains, and valuation questions as healthcare distribution remains in focus.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
